ARTICLE | Clinical News
Grazax regulatory update
March 20, 2006 8:00 AM UTC
The company received marketing approval in Sweden for Grazax a sublingual vaccine to treat grass pollen allergy. ALK will submit marketing applications in other EU member countries through the mutual ...